Espra DSR Capsule is a combination medication containing Domperidone 30mg and Esomeprazole 40mg, designed to provide effective relief from gastrointestinal disorders. Domperidone is a prokinetic agent that enhances gastrointestinal motility by blocking dopamine receptors, thereby facilitating faster gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, works by suppressing gastric acid secretion, promoting healing of acid-related damage, and providing relief from conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The synergistic action of these two components helps in managing symptoms associated with acid reflux, indigestion, and delayed gastric emptying. Espra DSR Capsule is particularly useful for patients experiencing persistent heartburn, regurgitation, and discomfort due to excessive stomach acid and impaired motility. It should be taken as prescribed by a healthcare professional, typically before meals, to maximize efficacy. Common side effects may include headache, dry mouth, or mild gastrointestinal disturbances. Patients with known hypersensitivity to either component or those with certain medical conditions should consult their physician before use. Espra DSR Capsule offers a comprehensive approach to managing upper gastrointestinal symptoms by combining acid suppression and motility enhancement in one convenient dosage form.